Dr Kelly McKelvey

Postdoctoral Research Fellow
Kolling Institute of Medical Research, Northern Clinical School

Telephone +61 2 99264830

Website Related website
Related website

Map

Biographical details

Dr Kelly McKelvey joined the Perinatal Research Laboratory at the Kolling Institute of Medical Research, University of Sydney in April 2014.

Research interests

My work investigates the immunological processes contributing to maternal and foetal death attributed to preeclampsia and associated complications.

Preeclampsia is a condition during pregnancy characterised by high blood pressure and high levels of protein in the urine. I affects 10 million pregnant women world-wide each year are leads to the deaths of 500,000 babies and 76,000 women.

My work utilises a mouse model (CBAxDBA) of spontaneous fetal death that mimics aspects of human preeclampsia, including high fetal morbidity and growth restriction of the babies that survive. Critically my work investigates how tiny vesciles called exosomes, regulate the immune system during a healthy pregnancy and what goes wrong during the preeclamptic disease process. We aim to translate this work into a novel therapy for treatment of preeclampsia to save the lives of both mother and baby.

Teaching and supervision

Research only.

Current projects

"Working towards a new therapy for the prevention of impaired fetal growth" - NHMRC grant (2014-2016)

Selected grants

2011

  • Effects of activated protein C on B-lymphocytes in Rheumatoid arthritis; McKelvey K; Ulysses Club Arthritis Research Fund/Research Fellowship.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • McKelvey, K., Jackson, C., Xue, M. (2014). Activated protein C: A regulator of human skin epidermal keratinocyte function. World Journal of Biological Chemistry, 5(2), 169-179. [More Information]
  • Xue, M., Shen, K., McKelvey, K., Li, J., Chan, Y., Hatzis, V., March, L., Little, C., Tonkin, M., Jackson, C. (2014). Endothelial protein C receptor associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2. Arthritis Research and Therapy, 16(1), R44. [More Information]
  • Julovi, S., Shen, K., McKelvey, K., Minhas, N., March, L., Jackson, C. (2013). Activated Protein C Inhibits Proliferation and Tumour Necrosis Factor alpha-stimulated Activation of p38, c-Jun NH2-Terminal Kinase (JNK) and Akt in Rheumatoid Synovial Fibroblasts. Molecular Medicine, 19, 324-331. [More Information]
  • Whitmont, K., Fulcher, G., Reid, I., Xue, M., McKelvey, K., Xie, Y., Aboud, M., Ward, C., Smith, M., Cooper, A., March, L., Jackson, C. (2013). Low Circulating Protein C Levels Are Associated with Lower Leg Ulcers in Patients with Diabetes. BioMed Research International, 2013, 1-4. [More Information]
  • McKelvey, K., Xue, M., Whitmont, K., Shen, K., Cooper, A., Jackson, C. (2012). Potential anti-inflammatory treatments for chronic wounds. Wound Practice & Research, 20(2), 86-89.
  • McKelvey, K., Highton, J., Hessian, P. (2011). Cell-specific expression of TLR9 isoforms in inflammation. Journal of Autoimmunity, 36(1), 78-86. [More Information]

2014

  • McKelvey, K., Jackson, C., Xue, M. (2014). Activated protein C: A regulator of human skin epidermal keratinocyte function. World Journal of Biological Chemistry, 5(2), 169-179. [More Information]
  • Xue, M., Shen, K., McKelvey, K., Li, J., Chan, Y., Hatzis, V., March, L., Little, C., Tonkin, M., Jackson, C. (2014). Endothelial protein C receptor associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2. Arthritis Research and Therapy, 16(1), R44. [More Information]

2013

  • Julovi, S., Shen, K., McKelvey, K., Minhas, N., March, L., Jackson, C. (2013). Activated Protein C Inhibits Proliferation and Tumour Necrosis Factor alpha-stimulated Activation of p38, c-Jun NH2-Terminal Kinase (JNK) and Akt in Rheumatoid Synovial Fibroblasts. Molecular Medicine, 19, 324-331. [More Information]
  • Whitmont, K., Fulcher, G., Reid, I., Xue, M., McKelvey, K., Xie, Y., Aboud, M., Ward, C., Smith, M., Cooper, A., March, L., Jackson, C. (2013). Low Circulating Protein C Levels Are Associated with Lower Leg Ulcers in Patients with Diabetes. BioMed Research International, 2013, 1-4. [More Information]

2012

  • McKelvey, K., Xue, M., Whitmont, K., Shen, K., Cooper, A., Jackson, C. (2012). Potential anti-inflammatory treatments for chronic wounds. Wound Practice & Research, 20(2), 86-89.

2011

  • McKelvey, K., Highton, J., Hessian, P. (2011). Cell-specific expression of TLR9 isoforms in inflammation. Journal of Autoimmunity, 36(1), 78-86. [More Information]

To update your profile click here. For support on your academic profile contact .